z-logo
open-access-imgOpen Access
Long term outcome of Aldosteronism after target treatments
Author(s) -
VinCent Wu,
Shuo-Meng Wang,
ChiaHui Chang,
Yahui Hu,
LianYu Lin,
YenHung Lin,
Shih-Chieh Chueh,
Likwang Chen,
KwanDun Wu
Publication year - 2016
Publication title -
scientific reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.24
H-Index - 213
ISSN - 2045-2322
DOI - 10.1038/srep32103
Subject(s) - primary aldosteronism , medicine , adrenalectomy , mineralocorticoid receptor , medical prescription , hyperaldosteronism , proportional hazards model , aldosterone , eplerenone , spironolactone , mace , urology , cardiology , pharmacology , myocardial infarction , conventional pci
There exists a great knowledge gap in terms of long-term effects of various surgical and pharmacological treatments on outcomes among primary aldosteronism (PA) patients. Using a validated algorithm, we extracted longitudinal data for all PA patients diagnosed in 1997–2010 and treated in the Taiwan National Health Insurance. We identified 3362 PA patients for whom the mean length of follow-up was 5.75 years. PA has higher major cardiovascular events (MACE) than essential hypertension (23.3% vs 19.3%, p = 0.015). Results from the Cox model suggest a strong effect of adrenalectomy on lowering mortality (HR = 0.23 with residual hypertension and 0.21 with resolved hypertension). While need for receptor antagonist (MRA) MRA after diagnosis suggests that a defined daily dose (DDD) of MRA between 12.5 and 50 mg may alleviate risk of death in a U-shape pattern. A specificity test identified patients who has aldosterone producing adenoma (HR = 0.50, p = 0.005) also confirmed adrenalectomy attenuated all-cause mortality. Adrenalectomy decreases long-term all-cause mortality independently from PA cure from hypertension. Prescription corresponding to a DDD between 12.5 and 50 mg may decrease mortality for patients needing MRA. It calls for more attention on early diagnosis, early treatment and prescription of appropriate dosage of MRA for PA patients.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here